(Q42683530)

4 November 2017

title

N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis (English)

1 reference

4 November 2017

0 references

3

1 reference

4 November 2017

Alessandro Trentini

1

0 references

Marinus Blankenstein

Marinus A Blankenstein

10

0 references

Tiziana Bellini

Tiziana Bellini

12

0 references

Charlotte Teunissen

13

Charlotte E Teunissen

1 reference

4 November 2017

5

Joep Killestein

1 reference

4 November 2017

Manuel Comabella Lopez

2

Manuel Comabella

1 reference

Marleen J A Koel-Simmelink

4 November 2017

4

Marleen J A Koel-Simmelink

1 reference

4 November 2017

8

Carsten Korth

1 reference

4 November 2017

Birthe Roos

6

1 reference

4 November 2017

Alex Rovira

7

1 reference

4 November 2017

Philipp Ottis

9

1 reference

4 November 2017

Xavier Montalban

11

1 reference

4 November 2017

publication date

17 September 2014

1 reference

4 November 2017

1 reference

4 November 2017

volume

261

1 reference

4 November 2017

issue

12

1 reference

4 November 2017

page(s)

2338-2343

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-014-7507-4

4 November 2017

exact match

0 references

cites work

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Neurofilament ELISA validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7507-4

A comparative study of CSF neurofilament light and heavy chain protein in MS

21 January 2018

1 reference

12 December 2020

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

12 December 2020

Neurofilament light as a prognostic marker in multiple sclerosis

1 reference

12 December 2020

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

1 reference

12 December 2020

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

1 reference

12 December 2020

The new global multiple sclerosis severity score (MSSS) correlates with axonal but not glial biomarkers

1 reference

12 December 2020

10.1007/S00415-014-7507-4

Identifiers

DOI

1 reference

4 November 2017

1 reference